Aussie rules: 'Game-changing' 3D cell culture developer looks to expand US footprint, raises $25m
Australia company, Inventia Life Science, which is focused on advanced 3D cell cultures for research and clinical purposes, has just closed a US$25M Series B funding round, led by Blackbird Ventures.